These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3699101)

  • 1. Evidence for dopaminomimetic effect of intrastriatally injected cholecystokinin octapeptide in mice.
    Worms P; Martinez J; Briet C; Castro B; Biziere K
    Eur J Pharmacol; 1986 Mar; 121(3):395-401. PubMed ID: 3699101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
    Kovács GL; Szabó G; Penke B; Telegdy G
    Eur J Pharmacol; 1981 Jan; 69(3):313-9. PubMed ID: 6260512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by beta-endorphin and morphine administered intracerebroventricularly in mice.
    Suh HH; Tseng LF
    Eur J Pharmacol; 1990 Apr; 179(3):329-38. PubMed ID: 2142090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of proglumide on mesolimbic and nigrostriatal dopamine function.
    Csernansky JG; Glick S; Mellentin J
    Psychopharmacology (Berl); 1987; 91(4):440-4. PubMed ID: 3108924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin-GABA interactions in rat striatum.
    Rakovska A
    Neuropeptides; 1995 Nov; 29(5):257-62. PubMed ID: 8587661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cholecystokinin on acetylcholine turnover and dopamine release in the rat striatum and cortex.
    Cosi C; Altar AC; Wood PL
    Eur J Pharmacol; 1989 Jun; 165(2-3):209-14. PubMed ID: 2776829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin facilitates ejaculation in male rats: blockade with proglumide and apomorphine.
    Pfaus JG; Phillips AG
    Eur J Pharmacol; 1987 Sep; 141(3):331-8. PubMed ID: 3666030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin-dopamine receptor interactions as studied with cholecystokinin receptor antagonists.
    Murphy RB
    Prog Clin Biol Res; 1985; 192():105-13. PubMed ID: 3001746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
    Katsuura G; Hsiao S; Itoh S
    Peptides; 1984; 5(3):529-34. PubMed ID: 6089145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cholecystokinin on apomorphine-induced changes of motility in rats.
    Katsuura G; Itoh S; Rehfeld JF
    Neuropharmacology; 1984 Jul; 23(7A):731-4. PubMed ID: 6089021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide.
    Tanimoto K; Tamminga CA; Chase TN; Nilaver G
    Endocrinology; 1987 Jul; 121(1):127-32. PubMed ID: 3297634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
    Crawley JH
    Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic-like effects of ceruletide and cholecystokinin octapeptide: interactions with apomorphine, methylphenidate and picrotoxin.
    Zetler G
    Eur J Pharmacol; 1983 Oct; 94(3-4):261-70. PubMed ID: 6140174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin modulation of apomorphine- or amphetamine-induced stereotypy in rats: opposite effects.
    Tieppo CA; Felicio LF; Nasello AG
    Peptides; 2001 Aug; 22(8):1291-8. PubMed ID: 11457523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin octapeptide and caerulein injection into the dorsomedial nucleus accumbens potentiate apomorphine-induced jaw movements in rats.
    Koshikawa N; Kikuchi de Beltrán K; Saigusa T; Kobayashi M; Stephenson JD
    Eur J Pharmacol; 1991 Dec; 209(1-2):75-80. PubMed ID: 1814762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrastriatal injection of kainic acid prevents the development of postsynaptic dopamine receptor hypersensitivity after chronic haloperidol treatment.
    Zarkovsky AM; Nurk AM; Rägo LK; Allikmets LH
    Neuropharmacology; 1982 Feb; 21(2):155-8. PubMed ID: 7199630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological effects of cholecystokinin octapeptide on identified rat nigrostriatal dopaminergic neurons.
    Freeman AS; Chiodo LA
    Brain Res; 1988 Jan; 439(1-2):266-74. PubMed ID: 3359189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antagonism by proglumide of various CCK-mediated effects in mice.
    Barbaz BS; Autry WL; Ambrose FG; Gerber R; Liebman JM
    Prog Clin Biol Res; 1985; 192():151-8. PubMed ID: 4080708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effect of cholecystokinin octapeptide on experimental amnesia in rats.
    Katsuura G; Itoh S
    Peptides; 1986; 7(1):105-10. PubMed ID: 3714527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebroventricular administration of cholecystokinin reduces stereotypy in dopamine-supersensitive rats.
    Tieppo CA; Silva AM; Palermo-Neto J; Nasello AG; Felicio LF
    Braz J Med Biol Res; 1995 Mar; 28(3):351-4. PubMed ID: 8520531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.